Archived story1 article · 1 publisher
Tech Talk: Israeli firm wins landmark FDA clearance for injection-based diabetes app
- Published
- Updated
- Reports
- 1 from 1 publisher
Petah Tikva-based DreaMed Diabetes has just received FDA 510(k) clearance for MODI, a prescription medical application that automatically optimizes...
How the outlets frame it
1 outlet, each read from its own headline and openingTap a logo to see the outlet, the headline it was read from, and where it sits on every measure.
Does the report cast the development as bad news or good news?
Only The Jerusalem Post could be placed, as positive.
Does the report play the story up to grab attention?
Only The Jerusalem Post could be placed, as mildly sensational.
Do the words judge rather than describe?
Only The Jerusalem Post could be placed, as some charged words.
Does the report give room to one side only?
Only The Jerusalem Post could be placed, as straight.
All 1 outlet and the headlines they were read from
The Jerusalem Post
Tech Talk: Israeli firm wins landmark FDA clearance for injection-based diabetes appFraming: Positive · Sensationalism: Mildly sensational · Loaded language: Some charged words · Slant: Straight
Each outlet is read blind: a classifier sees its headline and opening next to the story's own headline, without the outlet's name, and scores how the report presents the story. A logo sits at the classifier's average reading, so it can fall between two levels. These readings compare coverage of this story only; they are not ratings of the outlets.
The story as a whole
Read from all the reports togetherSingle event
Not political
No violence reported
Other signals
4 found · 18 not present- Government levelFederal
- What a reader getsNew facts
- Market relevanceRelevant to markets
- Public healthA treatment or drug
- Article typenot present
- Topicnot present
- Policy areanot present
- Where it happensnot present
- Tonenot present
- Viewpoints presentednot present
- Main political actornot present
- Civil liberties questionnot present
- Which marketnot present
- Market horizonnot present
- Who is economically affectednot present
- Corporate dimensionnot present
- Conflict dimensionnot present
- Conflict direction reportednot present
- Humanitarian impactnot present
- Public safetynot present
- Scientific evidencenot present
- Legal risk in the reportingnot present
The 10 stories everyone is covering, in your inbox at 7 am your time.
grouped.news is free, independent and has no paywall. If it saves you time, chip in.Buy us a coffee ↗